Agenda

TUESDAY, MARCH 31

All Times - EST Time Zone

8:30am // REGISTRATION AND BREAKFAST

9:00am // OPENING REMARKS

9:10am // KEYNOTE TALK - Dr. Ronan O'Hagan, CEO, Bectas Therapeutics | Former Executive Director, Oncology Drug Discovery for Merck | Former CSO, Xilio Therapeutics. Topic: The Latest in Drug Discovery and Development

9:40am // Corporate Presentation - Hua Medicine (HKEX:2552)

9:55am // Corporate Presentation - Bectas Therapeutics

10:10am // Corporate Presentation - MAXONA Pharmaceutical

10:25am // Corporate Presentation - Alphyn Biologics

10:40am // Corporate Presentation - KahrBio

10:55am // Corporate Presentation - Rejuvenation Technologies

11:10am // Corporate Presentation - Vesselon

11:25am // Corporate Presentation - Zipcode Bio Therapeutics

11:40am // Corporate Presentation - Duo Oncology

11:55am // Corporate Presentation - Imbrium Therapeutics

12:10pm // Corporate Presentation - PAVAJ Vascular

12:25pm // LUNCH BREAK

1:20pm // Corporate Presentation - Stingray Therapeutics

1:35pm // Corporate Presentation - DNA Nanobots

1:50pm // Corporate Presentation - PredxBio

2:05pm // Corporate Presentation - Sustained Therapeutics

2:20pm // Corporate Presentation - Maipl Therapeutics

2:35pm // Corporate Presentation - Galibra Neuroscience

2:50pm // Corporate Presentation - Allander Biotechnologies

3:05pm // Corporate Presentation - Ridgeline Therapeutics

3:20pm // Corporate Presentation - RealNose

3:35pm // Corporate Presentation - Apricity Health

3:50pm // SPEAKERS - Steven Ferguson, Deputy Director, Deputy Director, Licensing and Entrepreneurship, NIH; Dr. Michael Salgaller, Supervisor, Technology Analysis and Marketing Unit (TAMU). Topic: NIH as Your Strategic Partner: Beyond Funding to Market Success

4:20pm // SPEAKER - Lillian Kim, Partner, Pillsbury. Topic: Alignment Under Pressure: How Incentives Shape Deal Outcomes in Life Sciences

4:45pm // SPEAKER - Dr. Phil Friedlander, Assistant Professor, Medicine, Hematology and Medical Oncology, Mt. Sinai TOPIC: Role for Lifileucel TIL in Melanoma

5:15pm // PANEL - VENTURE CAPITAL INVESTOR PANEL. Moderator: Bill Werkmeister, MedInvest. Panelists: Allan Gobbs, Founder & Managing Partner, ATEM Capital; Brooke Raphael, COO, Avicella Capital; Max Colbert, Associate, Medical Excellence Capital

6:00pm // CLOSING REMARKS

6:10pm // RECEPTION

WEDNESDAY, APRIL 1

All Times - EST Time Zone

8:30am // REGISTRATION AND BREAKFAST

9:00am // OPENING REMARKS

9:10am // KEYNOTE TALK - Dr. Alfred Slanetz, Former CEO, Bluebird Bio | Chairman, National Foundation for Cancer Research. Topic: Bluebird Bio: What Went Right, What Went Wrong

9:40am // Corporate Presentation - IMUNON (Nasdq: IMNN)

9:55am // Corporate Presentation - ScorePharma

10:10am // Corporate Presentation - Oban BioPharma

10:25am // Corporate Presentation - SciTech Development

10:40am // Corporate Presentation - Zena Therapeutics

10:55am // Corporate Presentation - Illumen Therapeutics

11:10am // Corporate Presentation - Canary Cure

11:25am // Corporate Presentation - AltrixBio

11:40am // Corporate Presentation - DigiTwin

11:55am // Corporate Presentation - Merakris Therapeutics

12:10pm // Corporate Presentation - Arcadia Medicine

12:25pm // LUNCH BREAK

1:10pm // Corporate Presentation - Hemogenyx Pharmaceuticals (HEMO.L)

1:25pm // Corporate Presentation - TNeuroDx

1:40pm // Corporate Presentation - Luminary Therapeutics

2:55pm // Corporate Presentation - Geneius Biotechnology

2:10pm // FEATURED SESSION - Dr. Daniel Henderson, Altruist Biologics | Innovent Biologics (IVBXF). Topic: From NMPA to FDA: Leveraging China's Data Advantage

2:30pm // SPEAKER - Steven Green, Partner, Pillsbury. Topic: Founder Power vs. Fiduciary Risk: Series A Governance After Moelis, §144, and Tesla

3:00pm // SPEAKER - Dr. Darryl Davis, Professor, University of Ottawa. Topic: Exosomes in the Cardiac Space

3:30pm // Corporate Presentation - Rhythm Biotherapeutics

3:45pm // FAMILY OFFICE PANEL DISCUSSION. Moderator: Bill Werkmeister, MedInvest. Panelists: Steven Abernathy, Founder and CEO, Abernathy Family Office; Sherry Grisewood, Senior Investment Officer, FoxHill Asset Management; Dan FarrelL, Founder and CEO, Privos Capital

4:30pm // CLOSING REMARKS

4:40pm // RECEPTION